483
Antares Pharma, IncFDA 483 - Antares Pharma, Inc - December 04, 2018
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Record Details
Antares Pharma, Inc. in Minneapolis, MN, was inspected by the FDA from November 27 to December 4, 2018. The inspection revealed that corrective and preventive action activities were not adequately documented. Specifically, Supplier Corrective Action Requests (SCARs) lacked proper documentation of actions and verification of effectiveness.
Open in Dashboard
ID · c43ea21c-3bfc-4ce8-9472-5dba268734d4